Figure 1
Proposed framework for classifying coexisting mitral regurgitation and severe LV systolic dysfunction. This framework is based on ancillary analyses of randomized clinical trials and prospective validation is pending. ERO: effective regurgitant orifice. EDV: end-diastolic volume. TMVr: transcatheter mitral valve repair. (from Bermejo J, Postigo A, Baumgartner H. The year in cardiovascular medicine 2020: valvular heart disease. See pages 647–656).

Proposed framework for classifying coexisting mitral regurgitation and severe LV systolic dysfunction. This framework is based on ancillary analyses of randomized clinical trials and prospective validation is pending. ERO: effective regurgitant orifice. EDV: end-diastolic volume. TMVr: transcatheter mitral valve repair. (from Bermejo J, Postigo A, Baumgartner H. The year in cardiovascular medicine 2020: valvular heart disease. See pages 647–656).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close